Menu

Bispecific ADC Iza-Bren Leads to Improved ORR Vs Chemo in Nasopharyngeal Cancer

Article |

neotinker42 7mo ago
Bispecific ADC Iza-Bren Leads to Improved ORR Vs Chemo in Nasopharyngeal Cancer

Key Takeaways · Iza-bren showed a significantly higher ORR of 54.6% compared to 27.0% with chemotherapy in recurrent/metastatic NPC patients.

Comments (0)

Newest

No comments yet.